Insulin pharmacology and regimens
How insulin signals through its receptor, how amino acid changes and formulation make rapid, basal and weekly analogues, how the kidney clears insulin, and the basal-bolus arithmetic, potassium shift and C-peptide questions Paper 1 asks.
Tier 1Medical sciences concept
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Insulin acts through a receptor tyrosine kinase. The PI3K-Akt branch drives GLUT4 translocation, glycogen synthesis and suppression of lipolysis and gluconeogenesis; the MAPK branch mediates growth.
- Analogues alter absorption from the subcutis by changing hexamer stability, isoelectric point or albumin binding. The receptor action is the same.
- About half of portal insulin is cleared by the liver on first pass, and the kidney clears about a third of systemic insulin. Insulin needs fall with kidney failure.
Loading the rest of the note…
Finished reading?
Sources
- Therapeutic Guidelines: DiabetesAU/NZTherapeutic Guidelines Limited, current eTG edition
- Australian Medicines HandbookAU/NZAustralian Medicines Handbook Pty Ltd, 2026
- Australian Type 2 Diabetes Glycaemic Management AlgorithmAU/NZAustralian Diabetes Society and NDSS, September 2026
- Australian Public Assessment Report for Awiqli (insulin icodec)AU/NZTherapeutic Goods Administration, 2025 (registered June 2024)
- Standards of Care in Diabetes 2026American Diabetes Association (Diabetes Care 2026;49 Suppl 1), 2026
- Hyperglycemic crises in adults with diabetes: a consensus reportDiabetes Care (Umpierrez GE et al., 2024;47:1257-75), 2024
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback